Tech Focus Asia
SEE OTHER BRANDS

Fresh science and technology news from Asia and the Pacific

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on August 28, 2025

Rocket Landing Accuracy Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends 2029

Rocket Landing Accuracy Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends 2029

The Business Research Company's Rocket Landing Accuracy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 28, 2025 /⁨EINPresswire.com⁩/ -- "Get 30% Off All Global Market Reports …

Rocket Launch Energy Recovery Market to Reach $2.7 Billion by 2029 with 14.5% CAGR

Rocket Launch Energy Recovery Market to Reach $2.7 Billion by 2029 with 14.5% CAGR

The Business Research Company's Rocket Launch Energy Recovery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 28, 2025 /⁨EINPresswire.com⁩/ -- "Get 30% Off All Global Market …

Kane Biotech Announces Second Quarter 2025 Financial Results

Kane Biotech Announces Second Quarter 2025 Financial Results

WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its second quarter 2025 financial results. Second Quarter 2025 Financial Highlights (Comparatives exclude …

NVIDIA Announces Upcoming Event for Financial Community

NVIDIA Announces Upcoming Event for Financial Community

SANTA CLARA, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- NVIDIA will present at the following event for the financial community: Goldman Sachs Communacopia + Technology Conference Monday, Sept. 8, 12:25 p.m. Pacific Time Interested parties can listen to the …

IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025

IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025

WASHINGTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced it will report fourth quarter and …

Trident Resources Announces Closing of the Acquisition of Claims from Eagle Plains Resources Within the La Ronge Gold Belt in Saskatchewan, Canada

Trident Resources Announces Closing of the Acquisition of Claims from Eagle Plains Resources Within the La Ronge Gold Belt in Saskatchewan, Canada

Vancouver, BC, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”)  is pleased to announce that, further to its news release dated August 12, 2025, it has closed the transaction with Eagle …

Biobatteries Industry to Reach $295.5 Million by 2040, Advancing at CAGR of 7.8%

Biobatteries Industry to Reach $295.5 Million by 2040, Advancing at CAGR of 7.8%

Biobatteries represent a breakthrough in sustainable energy storage, merging biotechnology with clean power generation. WILMINGTON, DE, UNITED STATES, August 28, 2025 /⁨EINPresswire.com⁩/ -- According to a new report published by Allied Market Research, …

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen to Present at Upcoming Healthcare Investor Conference

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

iRAYPLE Won Two Major Awards and Secured a Spot on the Prestigious 2025 Zhejiang Manufacturing Excellence List

iRAYPLE Won Two Major Awards and Secured a Spot on the Prestigious 2025 Zhejiang Manufacturing Excellence List

HANGZHOU, ZHEJIANG, CHINA, August 28, 2025 /⁨EINPresswire.com⁩/ -- iRAYPLE Won Two Major Awards and Secured a Spot on the Prestigious 2025 Zhejiang Manufacturing Excellence List 𝐑𝐞𝐜𝐨𝐠𝐧𝐢𝐳𝐞𝐝 𝐰𝐢𝐭𝐡 𝐃𝐮𝐚𝐥 𝐇𝐨𝐧𝐨𝐫𝐬 𝐢𝐧 𝐑𝐨𝐛𝐨𝐭𝐢𝐜𝐬 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 iRAYPLE's …

SPS Commerce to Present at Citi's 2025 Global TMT Conference

SPS Commerce to Present at Citi's 2025 Global TMT Conference

MINNEAPOLIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at Citi's 2025 Global TMT Conference on Thursday, September 4, 2025, at 8:10 AM E …

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, …

Nutanix to Present at Upcoming Investor Conference

Nutanix to Present at Upcoming Investor Conference

SAN JOSE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event: Goldman Sachs Communacopia + Technology …

Cardiff Oncology to Participate in Three Upcoming Investor Conferences

Cardiff Oncology to Participate in Three Upcoming Investor Conferences

SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will …

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced that …

Key Tronic Celebrates Grand Opening of New Manufacturing Facility in Springdale, Arkansas

Key Tronic Celebrates Grand Opening of New Manufacturing Facility in Springdale, Arkansas

SPRINGDALE, Ark., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation, a leading provider of electronic manufacturing services (EMS), announced the grand opening of its new, state-of-the-art manufacturing facility in Springdale, Arkansas. Company …

89bio to Participate in Upcoming Investor Conferences

89bio to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today …

atai Life Sciences to Participate in September Investor Conferences

atai Life Sciences to Participate in September Investor Conferences

NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September: Citi 2025 Biopharma Back to School …

Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate

Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate

CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it will host a webinar on Tuesday, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions